Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.8700
+0.0300 (1.63%)
NASDAQ· Last Trade: Jun 23rd, 5:53 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors